Crossmark Global Holdings’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$990K Buy
15,460
+294
+2% +$19.3K 0.01% 629
2026
Q1
$1.08M Sell
15,166
-462
-3% -$36.4K 0.02% 588
2025
Q4
$1.28M Buy
15,628
+6,447
+70% +$502K 0.02% 539
2025
Q3
$689K Buy
9,181
+73
+0.8% +$5.45K 0.01% 762
2025
Q2
$675K Buy
9,108
+75
+0.8% +$5.22K 0.01% 757
2025
Q1
$729K Sell
9,033
-259
-3% -$22.3K 0.01% 718
2024
Q4
$727K Buy
9,292
+25
+0.3% +$2.13K 0.01% 683
2024
Q3
$870K Buy
9,267
+1,801
+24% +$151K 0.02% 657
2024
Q2
$582K Sell
7,466
-13,352
-64% -$1.09M 0.01% 760
2024
Q1
$1.89M Sell
20,818
-581
-3% -$48.3K 0.04% 443
2023
Q4
$1.66M Sell
21,399
-248
-1% -$17.4K 0.03% 456
2023
Q3
$1.48M Buy
21,647
+36
+0.2% +$2.62K 0.03% 470
2023
Q2
$1.68M Buy
21,611
+1,405
+7% +$112K 0.04% 453
2023
Q1
$1.66M Buy
+20,206
New +$1.44M 0.04% 454

Other funds holding GEHC

Crossmark Global Holdings's GEHC Position: Q2 2026 in Review

Crossmark Global Holdings increased its GE HealthCare (GEHC) stake by 1.9% in Q2 2026, buying an estimated $19.3K and bringing the position to 15,460 shares worth $990K. The position accounts for 0.01% of the portfolio, ranked #629.

Crossmark Global Holdings first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.89M in Q1 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Crossmark Global Holdings held 15,460 shares of GE HealthCare worth $990K as of Q2 2026.
  • Crossmark Global Holdings bought 294 GE HealthCare shares in Q2 2026, an estimated $19.3K.
  • GE HealthCare made up 0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #629 holding.
  • Crossmark Global Holdings first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Crossmark Global Holdings's GE HealthCare position peaked at $1.89M in Q1 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.